Surgical Hemostats Market, By Product Type (Topical Thrombin-Based, Flowable, Collagen-Based, Oxidized Regenerated Cellulose-Based, Gelatin-Based, & Combination), Formulation (Matrix, Sponge, Powder), Application, End-use -Global Forecast (2024-2032)

List of Tables

Surgical Hemostats Market size is poised to expand at 5.6% CAGR from 2024 to 2032 driven by the concerted efforts to minimize postoperative complications.

Of late, surgeons are prioritizing effective hemostatic solutions to control bleeding during and after surgical procedures for reducing the risk of complications and improving patient outcomes. Healthcare professionals are increasingly emphasizing patient safety and recovery, surging the adoption of advanced hemostatic agents. The continuous development of innovative hemostatic technologies, aimed at enhancing efficacy and minimizing adverse effects will fuel the product adoption. Furthermore, the ongoing innovations in hemostatic agents, including the development of advanced materials and formulations to improve efficacy and applicability will contribute to the industry growth. For instance, in November 2023, Ethicon announced the approval of ETHIZIATM, a clinically certified supplementary hemostat solution to maintain hemostasis in circumstances of difficult-to-control bleeding.

The industry is segmented into product type, formulation, application, end-use, and region.

Based on product type, the collagen-based surgical hemostats market is projected to witness 5.2% CAGR between 2024 and 2032. This is owing to the increasing preference for collagen-based products for their versatility and ability to control bleeding effectively. Surgical hemostats provide hemostatic efficacy, biocompatibility, and ease of use in various surgical applications. Additionally, the natural hemostatic properties of collagen are surging its use for diverse surgeries, including orthopedic, cardiovascular, and dental procedures. Furthermore, technological advancements to enhance the performance and applicability of collagen-based hemostats will propel the segment growth.

In terms of end-use, the surgical hemostats industry from the ambulatory surgical centers segment is expected to record 5.4% growth rate through 2032. The growing patient preference for medical treatments at ambulatory surgical centers (ASCs) can be attributed to their efficiency, cost-effectiveness, and minimally invasive procedures. The rising need for effective bleeding control in diverse surgical interventions performed in outpatient settings is also fueling the product demand.

Asia Pacific surgical hemostats industry is set to exhibit 6% growth rate during 2024-2032 attributed to the rising surgical procedures, increasing healthcare infrastructure, and the growing awareness about advanced medical products. The surging prevalence of chronic diseases and elective surgeries is contributing to the higher demand for efficient hemostatic solutions. Moreover, government initiatives for promoting healthcare development coupled with the ongoing advancements in surgical techniques and the strong focus on minimizing postoperative complications will accelerate the regional industry expansion.

Product Code: 7748

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & working
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

2.1 Surgical hemostats industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product type trends
- 2.1.4 Formulation trends
- 2.1.5 Application trends
- 2.1.6 End-use trends

Chapter 3 Surgical Hemostats Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing number of surgical procedures globally
  - 3.2.1.2 Increasing incidence of accidents and trauma cases
  - 3.2.1.3 Rising technological advancements in hemostasis products
  - 3.2.1.4 Surge in government initiatives towards awareness regarding road traffic accidents
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High expense needed for hemostasis products due to the usage of advanced technology for hemostats
  - 3.2.2.2 Lack of skilled professionals for carrying out surgical procedures
3.3 Growth potential analysis
- 3.3.1 By product type
- 3.3.2 By formulation
- 3.3.3 By application
- 3.3.4 By end-use
3.4 Technology landscape
3.5 Pricing analysis
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023

Chapter 5 Surgical Hemostats Market Size and Forecast, By Product Type, 2018-2032 (USD Million)

5.1 Key trends, by product type
5.2 Topical thrombin-based hemostats
5.3 Flowable hemostats
5.4 Collagen-based hemostats
5.5 Oxidized regenerated cellulose-based hemostats
5.6 Gelatin-based hemostats
5.7 Combination hemostats
5.8 Other product types

Chapter 6 Surgical Hemostats Market Size and Forecast, By Formulation, 2018-2032 (USD Million)

6.1 Key trends, by formulation
6.2 Matrix & gel hemostats
6.3 Sponge hemostats
6.4 Sheet & pad hemostats
6.5 Powder hemostats

Chapter 7 Surgical Hemostats Market Size and Forecast, By Application, 2018-2032 (USD Million)

7.1 Key trends, by application
7.2 General surgery
7.3 Cardiovascular surgery
7.4 Orthopedic surgery
7.5 Gynecological surgery
7.6 Neurosurgery
7.7 Reconstructive surgery
7.8 Other applications

Chapter 8 Surgical Hemostats Market Size and Forecast, By End-use, 2018-2032 (USD Million)

8.1 Key trends, by end-use
8.2 Clinics
8.3 Hospitals
8.4 Ambulatory surgical centers
8.5 Other end-users

Chapter 9 Surgical Hemostats Market Size and Forecast, By Region, 2018-2032 (USD Million)

9.1 Key trends, by region
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 Japan
- 9.4.2 China
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East & Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 Rest of Middle East & Africa

Chapter 10 Company Profiles

10.1 Becton, Dickinson and Company
10.2 Medtronic plc
10.3 Teleflex Corporation
10.4 Baxter International Inc.
10.5 B. Braun Melsungen AG
10.6 Pfizer, Inc.
10.7 Ethicon, Inc. (Johnson & Johnson)
10.8 Stryker Corporation
10.9 CuraMedical BV
10.10 Gelita Medical GmbH
10.11 Integra LifeSciences
10.12 Marine Polymer Technologies, Inc.
10.13 Hemostasis LLC